These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20618808)

  • 1. Stability of 0.5% cidofovir stored under various conditions for up to 6 months.
    Stiles J; Gwin W; Pogranichniy R
    Vet Ophthalmol; 2010 Jul; 13(4):275-7. PubMed ID: 20618808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of human adenovirus type 5 variants resistant to the antiviral cidofovir.
    Gordon YJ; Araullo-Cruz TP; Johnson YF; Romanowski EG; Kinchington PR
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2774-8. PubMed ID: 8977495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of cidofovir in 0.9% sodium chloride injection and in 5% dextrose injection.
    Yuan LC; Samuels GJ; Visor GC
    Am J Health Syst Pharm; 1996 Aug; 53(16):1939-43. PubMed ID: 8862207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of ceftazidime in plastic syringes and glass vials under various storage conditions.
    Stewart JT; Warren FW; Johnson SM; Fox JL; Mullaney J
    Am J Hosp Pharm; 1992 Nov; 49(11):2765-8. PubMed ID: 1471643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of bortezomib 1-mg/mL solution in plastic syringe and glass vial.
    André P; Cisternino S; Chiadmi F; Toledano A; Schlatter J; Fain O; Fontan JE
    Ann Pharmacother; 2005 Sep; 39(9):1462-6. PubMed ID: 15985470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
    Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
    Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats.
    Fontenelle JP; Powell CC; Veir JK; Radecki SV; Lappin MR
    Am J Vet Res; 2008 Feb; 69(2):289-93. PubMed ID: 18241028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of genital herpesvirus infection in goats by cidofovir.
    Tempesta M; Camero M; Bellacicco AL; Tarsitano E; Crescenzo G; Thiry J; Martella V; Decaro N; Elia G; Neyts J; Thiry E; Buonavoglia C
    Antivir Ther; 2007; 12(6):977-9. PubMed ID: 17926653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of cidofovir in extemporaneously prepared syringes.
    Hennere G; Havard L; Bonan B; Prognon P
    Am J Health Syst Pharm; 2005 Mar; 62(5):506-9. PubMed ID: 15745914
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility of sea lion poxvirus to cidofovir.
    Nollens HH; Gulland FM; Jacobson ER; Hernandez JA; Klein PA; Walsh MT; Condit RC
    Antiviral Res; 2008 Oct; 80(1):77-80. PubMed ID: 18485494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Xa stability of diluted enoxaparin for use in pediatrics.
    Dager WE; Gosselin RC; King JH; Christensen CL; Owings JT; Larkin EC
    Ann Pharmacother; 2004 Apr; 38(4):569-73. PubMed ID: 14982984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of herpes simplex virus disease in patients who are receiving cidofovir.
    Wyles DL; Patel A; Madinger N; Bessesen M; Krause PR; Weinberg A
    Clin Infect Dis; 2005 Sep; 41(5):676-80. PubMed ID: 16080090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of cidofovir in 0.9% sodium chloride injection for five days.
    Ennis RD; Dahl TC
    Am J Health Syst Pharm; 1997 Oct; 54(19):2204-6. PubMed ID: 9331442
    [No Abstract]   [Full Text] [Related]  

  • 15. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Liekens S; Neyts J; De Clercq E; Verbeken E; Ribatti D; Presta M
    Cancer Res; 2001 Jul; 61(13):5057-64. PubMed ID: 11431341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
    Liekens S; Andrei G; Vandeputte M; De Clercq E; Neyts J
    Cancer Res; 1998 Jun; 58(12):2562-7. PubMed ID: 9635579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
    Neyts J; Sadler R; De Clercq E; Raab-Traub N; Pagano JS
    Cancer Res; 1998 Feb; 58(3):384-8. PubMed ID: 9458076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.